Liz Crowne
Wed 07 09:30
CME1.2
CME Day: Session 1
Hypogonadotrophic hypogonadism - challenges in diagnosis and management
Shankar Kanumakala
Wed 07 11:30
CMW2.2
CME Day: Session 2
Management of growth and body composition in Prader Willi syndrome
Alghanay
Wed 07 14:45
OC3.2
CME Day: Oral Communications 3
Haemolytic Uraemic Syndrome (HUS) – a rare cause of diabetes
Melanie Kershaw
Wed 07 15:50
CME4.2
CME Day: Session 4
Role of youth worker, family support and social worker in supporting diabetes management
Nicholas Shaw
Thu 08 16:00
SY2.2
Symposium 2
State of the Art Lecture: 20 years experience in Metabolic Bone
Fiona Campbell
Thu 08 16:00
S4.2
Diabetes Professionals Day: Session 4
AGAINST: This house believes that Automation has primacy over Education in management of diabetes
Trevor Cole
Fri 09 11:30
ND2.1
Nurses' Day for Endocrine Professionals: Session 2
Meet The Expert: Clincal differential diagnosis in short stature syndrome
Jenny Child
Fri 09 12:30
ND2.2
Nurses' Day for Endocrine Professionals: Session 2
Patient experience: Growing Up with Russell Silver Syndrome
Carlo Acerini
Thu 08 13:30
S3.1
Diabetes Professionals: Session 3
CGMS in children - current technologies and future prospects
Arameh Aghababaie
Fri 09 12:20
OC7.6
Diabetes Main Meeting: Oral Communications 7
Type A Insulin Resistance Syndrome due to anINSRmutation Presenting with Diabetes Mellitus Evolving to Hyperandrogenism and PCOS
Chizo Agwu
Fri 09 11:40
OC7.2
Diabetes Main Meeting: Oral Communications 7
Provision of Psychology Services for Children and Young People with Diabetes: A National Survey
Apoorva Aji
Wed 07 12:15
OC2.2
CME Day: Oral Communications 2
The relationship of baseline, incremental and peak cortisol following a Short Synacthen Test – single-centre analysis of three years’ data
Laila Al-Hashmi
Fri 09 10:30
OC8.1
Nurses Day for Endocrine Professionals: Oral Communications 8
Five year outcomes in a cohort with hypoglycaemia due to Congenital Hyperinsulinism
Nadia Amin
Leeds Teaching Hospital, Leeds, UK
Wed 07 14:30
OC3.1
CME Day: Oral Communications 3
Serial overnight growth hormone profiling in diagnosing growth hormone excess in McCune Albright Syndrome.
Leeds Teaching Hospital, Leeds, UK
Professor Wiebke Arlt
London, UK
Thu 08 12:00
SY1.3
Symposium 1
Novel androgen pathways and their role in CAH
London, UK
Paul Arundel
Wed 07 13:30
CME3.1
CME Day: Session 3
Approach to a child with recurrent fractures
Ved Arya
Thu 08 10:20
OC4.8
Endocrine Main Meeting: Oral Communications 4
Prolactinoma in Childhood and Adolescence – outcomes relating to the size of tumour
Irina A Bacila
Sheffield, UK
Thu 08 10:00
OC4.6
Endocrine Main Meeting: Oral Communications 4
Implementation of a novel non-invasive test for monitoring control in individuals with congenital adrenal hyperplasia
Sheffield, UK
Tim Barrett
UK
Thu 08 08:45
Endocrine Main Meeting: Welcome from Convenors
Welcome from Convenors
UK
Polly Bingley
Fri 09 09:30
SY3.1
Symposium 3
Lessons from TRIALNet
Gary Butler
Fri 09 09:30
ND1.1
Nurses' Day for Endocrine Professionals: Session 1
Gender Identity
Georgina Cameron
Wed 07 12:00
OC2.1
CME Day: Oral Communications 2
An Audit of Hypoglycemia screens in Paediatric and Neonatal Patients in Two District General Hospitals
Professor Li Chan
London, UK
Thu 08 09:40
OC4.4
Endocrine Main Meeting: Oral Communications 4
Identification and characterisation of a small-molecule ACTH receptor/Melanocortin-2-receptor antagonist
London, UK
Tim Cheetham
Newcastle, UK
Fri 09 15:00
SY5.2
Symposium 5
Thyrotoxicosis – what’s new and where are we going?
Newcastle, UK
Suet Ching Chen, MD
Glasgow, UK
Thu 08 14:18
OC5.9
Endocrine Main Meeting: Oral Communications 5
Diazoxide-induced pulmonary hypertension: UK multicentre retrospective study on the risk factors, monitoring approach andmanagement recommendations
Glasgow, UK
Fri 09 11:50
OC7.3
Diabetes Main Meeting: Oral Communications 7
The Determinants of Skeletal Morbidity And Fractures In Children With Type 1 Diabetes
Glasgow, UK
Amish Chinoy
Manchester, United Kingdom
Thu 08 11:20
OC6.3
Diabetes Professionals' Day: Oral Communications 6
Has the reduction in maintenance fluid rates following introduction of 2015 BSPED-recommended diabetic ketoacidosis guidelines impacted on complication rates?
Manchester, United Kingdom
Alexandra Costa
Thu 08 13:42
OC5.3
Endocrine Main Meeting: Oral Communications 5
Can novel stem cell models help unpick the pathogenesis of the Triple A Syndrome?
Dr Emily Cottrell
London, UK
Thu 08 14:06
OC5.7
Endocrine Main Meeting: Oral Communications 5
A novel GHR pseudoexon mutation causing frameshift and severe postnatal growth failure
London, UK
Thu 08 14:12
OC5.8
Endocrine Main Meeting: Oral Communications 5
Patients with short stature and GH/IGF-1 Insensitivity harbour Copy Number Variants causing a Silver-Russell-like Phenotype
London, UK
Antonia Dastamani
London, UK
Thu 08 10:10
OC4.7
Endocrine Main Meeting: Oral Communications 4
Clinical Outcomes of Focal Congenital Hyperinsulinism - A UK Perspective
London, UK
Nikki Davis
Southampton, United Kingdom
Wed 07 11:00
CME2.1
CME Day: Session 2
Management of Obesity- what works ?
Southampton, United Kingdom
Christine Desmond
Thu 08 10:05
PENS1.2
PENS Presentation Session
PENS BSPED Prize: The Implementation of a Nurse Led Virtual Thyroid Clinic
Libby Dowling
Thu 08 09:30
S1.2
Diabetes Professionals Day: Session 1
Social media and diabetes management - does it work?
Sian Ellard
Fri 09 14:30
SY4.1
Symposium 4
Diagnosis of Monogenic Diabetes
Elspeth Ferguson
Sheffield, UK
Wed 07 10:15
OC1.2
CME Day: Oral Communications 1
The complications of a goitre secondary to iodine deficiency
Sheffield, UK
Fri 09 12:30
OC7.7
Diabetes Main Meeting: Oral Communications 7
Knowledge and Confidence of Paediatric Middle Grade Doctors in Managing Out of Hours Diabetes Advice Calls
Sheffield, UK
James Greening
Fri 09 11:30
OC7.1
Diabetes Main Meeting: Oral Communications 7
DeAPP (Diabetes Education APP): using flipped learning to deliver structured education in newly diagnosed type 1 diabetes patients
Martin Hewison
Birmingham, UK
Thu 08 15:30
SY2.1
Symposium 2
Vitamin D - Beyond Bone
Birmingham, UK
Peter Hindmarsh
Thu 08 13:48
OC5.4
Endocrine Main Meeting: Oral Communications 5
Fourteen years experience of hydrocortisone pump therapy for cortisol replacement in adrenal insufficiency
David Hodson
Oxford, UK
Fri 09 15:30
SY4.3
Symposium 4
Beta Cell function and prospects for new treatments
Oxford, UK
Dr Sasha Howard
London, UK
Thu 08 09:50
OC4.5
Endocrine Main Meeting: Oral Communications 4
Delayed or Absent? - Use of Next Generation Sequencing Diagnostic Tools in a UK Puberty Cohort
London, UK
Zilla Huma
Thu 08 13:36
OC5.2
Endocrine Main Meeting: Oral Communications 5
Screening for Co-Morbidities in Fibrous Dysplasia
Jan Idkowiak
Birmingham, UK
Fri 09 12:10
OC7.5
Diabetes Main Meeting: Oral Communications 7
Diabetes control is worse in children and young people with type 1 diabetes requiring interpreter support
Birmingham, UK
Charlotte Jackson
Fri 09 12:00
OC7.4
Diabetes Main Meeting: Oral Communications 7
Parental language proficiency and glycaemic control in children with type 1 diabetes
Tobin Joseph
Fri 09 10:40
OC8.2
Nurses Day for Endocrine Professionals: Oral Communications 8
The effect of GnRHa treatment on bone density in young adolescents with gender dysphoria: findings from a large national cohort
Niki Karavitaki
Birmingham, UK
Fri 09 14:30
SY5.1
Symposium 5
Pituitary Tumours
Birmingham, UK
Melanie Kershaw
Thu 08 11:00
OC6.1
Diabetes Professionals' Day: Oral Communications 6
A Retrospective Regional Analysis of Outcomes during Transition of Young People with Type 1 Diabetes
Jeremy Kirk
Birmingham, UK
Wed 07 14:00
CME3.2
CME Day: Session 3
Assessment and management of Tall stature
Birmingham, UK
Fri 09 15:30
SY5.3
Symposium 5
State of the Art Lecture: NESGAS
Birmingham, UK
Nils Krone
Sheffield, UK
Thu 08 11:00
SY1.1
Symposium 1
Diagnostic approach to expanding aetiologies of DSD
Sheffield, UK
Alexander Lewis
Cardiff, UK
Thu 08 09:10
OC4.1
Endocrine Main Meeting: Oral Communications 4
Hydrocortisone granules in capsules for opening: phase 3 trial in children with adrenal insufficiency and long-term safety data
Cardiff, UK
Oluwakemi Lokulo-Sodipe
Southampton, UK
Thu 08 13:30
OC5.1
Endocrine Main Meeting: Oral Communications 5
Growth outcomes in adolescents and adults with Silver-Russell syndrome and the effects of childhood growth hormone treatment.
Southampton, UK
Allison Low
Thu 08 11:10
OC6.2
Diabetes Professionals' Day: Oral Communications 6
Perceptions of diabetes education: a questionnaire-based survey of 117 patients and families.
Kate Morgan
Thu 08 09:45
PENS1.1
PENS Presentation Session
Polycystic Kidney Disease with Hyperinsulinemic hypoglycaemia
Parth Narendran
Birmingham, UK
Fri 09 10:15
SY3.2
Symposium 3
EXTOD - lessons for CYP
Birmingham, UK
May Ng
UK
Thu 08 14:00
S3.2
Diabetes Professionals: Session 3
Practical Approach to Management of CGM and Flash Glucose (Libre) Systems for Children and Young People with T1DM
UK
Katharine Owen
Thu 08 11:30
S2.1
Diabetes Professionals Day: Session 2
Type 2 diabetes: insights from the adult clinic
Meera Parmar
Fri 09 12:40
OC7.8
Diabetes Main Meeting: Oral Communications 7
Continuous Glucose Monitoring with Regular Clinical Review of Glycaemic Control in Children with Type 1 Diabetes Experiencing Frequent Unpredictable Hypoglycaemia.
John Pemberton
Birmingham, UK
Thu 08 09:00
S1.1
Diabetes Professionals Day: Session 1
Diasend Project
Birmingham, UK
Catherine Peters
London, UK
Fri 09 15:00
SY4.2
Symposium 4
Management of CF-Related Diabetes
London, UK
Tabitha Randell
Nottingham, UK
Thu 08 15:30
S4.1
Diabetes Professionals Day: Session 4
FOR: This house believes that Automation has primacy over Education in management of diabetes
Nottingham, UK
Martin Savage
London, UK
Wed 07 09:00
CME1.1
CME Day: Session 1
Techniques to maximise childhood and adult height
London, UK
Adam Stevens
Manchester, United Kingdom
Thu 08 09:20
OC4.2
Endocrine Main Meeting: Oral Communications 4
Gene expression signatures in children with growth hormone deficiency (GHD) and Turner syndrome (TS) predict response to growth hormone
Manchester, United Kingdom
Xanthippi Tseretopoulou
Wed 07 10:00
OC1.1
CME Day: Oral Communications 1
Differentiating between SIADH and NSIAD in an infant presenting with hyponatraemia
Ian Tucker
Thu 08 14:00
OC5.6
Endocrine Main Meeting: Oral Communications 5
Successes and challenges around cohorted introduction of Burosumab in clinical treatment of X-Linked Hypophosphataemia (XLH)
Anthony Waldron
Thu 08 16:30
S5
Key Note Speaker: Session 5
Palaeopathology; diseases and excavations
Thu 08 16:30
S5
Key Note Speaker: Session 5
Palaeopathology; diseases and excavations
Sandra Walton-Betancourth
Fri 09 10:50
OC8.3
Nurses Day for Endocrine Professionals: Oral Communications 8
Attitudes Toward Fertility and Reproductive Health Among Transgender Adolescents
Robert Wheeler
Thu 08 11:30
SY1.2
Symposium 1
DSD surgery; the child’s best interests, and disclosure prior to consent
Billy White
London, United Kingdom
Thu 08 12:00
S2.2
Diabetes Professionals Day: Session 2
New Therapies in Type 2 diabetes
London, United Kingdom
Ingrid Wilkinson
Thu 08 13:54
OC5.5
Endocrine Main Meeting: Oral Communications 5
New insights into the Low Dose Dexamethasone Suppression Test in paediatric Cushing’s Syndrome (CS)
Prateek Yadev
Thu 08 09:30
OC4.3
Endocrine Main Meeting: Oral Communications 4
Recommendations for management of paediatric phaeochromocytoma/paraganglioma (PCC/PGL):On behalf of the UK Paediatric PCC/PGL Guideline Development Group.
Thu 08 09:00
S1.1
Diabetes Professionals Day: Session 1
Diasend Project
Birmingham, UK
Thu 08 09:30
S1.2
Diabetes Professionals Day: Session 1
Social media and diabetes management - does it work?
Thu 08 10:00
S1.3
Diabetes Professionals Day: Session 1
Optimising Transition in Young Adults with Diabetes - the importance of hope?
Thu 08 11:30
S2.1
Diabetes Professionals Day: Session 2
Type 2 diabetes: insights from the adult clinic
Thu 08 12:00
S2.2
Diabetes Professionals Day: Session 2
New Therapies in Type 2 diabetes
London, United Kingdom
Thu 08 13:30
S3.1
Diabetes Professionals: Session 3
CGMS in children - current technologies and future prospects
Thu 08 14:00
S3.2
Diabetes Professionals: Session 3
Practical Approach to Management of CGM and Flash Glucose (Libre) Systems for Children and Young People with T1DM
UK
Thu 08 15:30
S4.1
Diabetes Professionals Day: Session 4
FOR: This house believes that Automation has primacy over Education in management of diabetes
Nottingham, UK
Thu 08 16:00
S4.2
Diabetes Professionals Day: Session 4
AGAINST: This house believes that Automation has primacy over Education in management of diabetes
Thu 08 16:30
S5
Key Note Speaker: Session 5
Palaeopathology; diseases and excavations
Fri 09 08:15
Sponsored Symposium
Fri 09 09:30
SY3.1
Symposium 3
Lessons from TRIALNet
Fri 09 10:15
SY3.2
Symposium 3
EXTOD - lessons for CYP
Birmingham, UK
Fri 09 13:00
Diabetes UK Update
The Studio
Fri 09 14:30
SY4.1
Symposium 4
Diagnosis of Monogenic Diabetes
Fri 09 15:00
SY4.2
Symposium 4
Management of CF-Related Diabetes
London, UK
Fri 09 15:30
SY4.3
Symposium 4
Beta Cell function and prospects for new treatments
Oxford, UK
Wed 07 10:00
OC1.1
CME Day: Oral Communications 1
Differentiating between SIADH and NSIAD in an infant presenting with hyponatraemia
Wed 07 10:15
OC1.2
CME Day: Oral Communications 1
The complications of a goitre secondary to iodine deficiency
Sheffield, UK
Wed 07 12:00
OC2.1
CME Day: Oral Communications 2
An Audit of Hypoglycemia screens in Paediatric and Neonatal Patients in Two District General Hospitals
Wed 07 12:15
OC2.2
CME Day: Oral Communications 2
The relationship of baseline, incremental and peak cortisol following a Short Synacthen Test – single-centre analysis of three years’ data
Wed 07 14:30
OC3.1
CME Day: Oral Communications 3
Serial overnight growth hormone profiling in diagnosing growth hormone excess in McCune Albright Syndrome.
Leeds Teaching Hospital, Leeds, UK
Wed 07 14:45
OC3.2
CME Day: Oral Communications 3
Haemolytic Uraemic Syndrome (HUS) – a rare cause of diabetes
Thu 08 11:00
OC6.1
Diabetes Professionals' Day: Oral Communications 6
A Retrospective Regional Analysis of Outcomes during Transition of Young People with Type 1 Diabetes
Thu 08 11:10
OC6.2
Diabetes Professionals' Day: Oral Communications 6
Perceptions of diabetes education: a questionnaire-based survey of 117 patients and families.
Thu 08 11:20
OC6.3
Diabetes Professionals' Day: Oral Communications 6
Has the reduction in maintenance fluid rates following introduction of 2015 BSPED-recommended diabetic ketoacidosis guidelines impacted on complication rates?
Manchester, United Kingdom
Thu 08 07:45
Sponsored Symposium
Thu 08 08:45
Endocrine Main Meeting: Welcome from Convenors
Welcome from Convenors
UK
Thu 08 09:10
OC4.1
Endocrine Main Meeting: Oral Communications 4
Hydrocortisone granules in capsules for opening: phase 3 trial in children with adrenal insufficiency and long-term safety data
Cardiff, UK
Thu 08 09:20
OC4.2
Endocrine Main Meeting: Oral Communications 4
Gene expression signatures in children with growth hormone deficiency (GHD) and Turner syndrome (TS) predict response to growth hormone
Manchester, United Kingdom
Thu 08 09:30
OC4.3
Endocrine Main Meeting: Oral Communications 4
Recommendations for management of paediatric phaeochromocytoma/paraganglioma (PCC/PGL):On behalf of the UK Paediatric PCC/PGL Guideline Development Group.
Thu 08 09:40
OC4.4
Endocrine Main Meeting: Oral Communications 4
Identification and characterisation of a small-molecule ACTH receptor/Melanocortin-2-receptor antagonist
London, UK
Thu 08 09:50
OC4.5
Endocrine Main Meeting: Oral Communications 4
Delayed or Absent? - Use of Next Generation Sequencing Diagnostic Tools in a UK Puberty Cohort
London, UK
Thu 08 10:00
OC4.6
Endocrine Main Meeting: Oral Communications 4
Implementation of a novel non-invasive test for monitoring control in individuals with congenital adrenal hyperplasia
Sheffield, UK
Thu 08 10:10
OC4.7
Endocrine Main Meeting: Oral Communications 4
Clinical Outcomes of Focal Congenital Hyperinsulinism - A UK Perspective
London, UK
Thu 08 10:20
OC4.8
Endocrine Main Meeting: Oral Communications 4
Prolactinoma in Childhood and Adolescence – outcomes relating to the size of tumour
Thu 08 11:00
SY1.1
Symposium 1
Diagnostic approach to expanding aetiologies of DSD
Sheffield, UK
Thu 08 11:30
SY1.2
Symposium 1
DSD surgery; the child’s best interests, and disclosure prior to consent
Thu 08 12:00
SY1.3
Symposium 1
Novel androgen pathways and their role in CAH
London, UK
Thu 08 13:30
OC5.1
Endocrine Main Meeting: Oral Communications 5
Growth outcomes in adolescents and adults with Silver-Russell syndrome and the effects of childhood growth hormone treatment.
Southampton, UK
Thu 08 13:36
OC5.2
Endocrine Main Meeting: Oral Communications 5
Screening for Co-Morbidities in Fibrous Dysplasia
Thu 08 13:42
OC5.3
Endocrine Main Meeting: Oral Communications 5
Can novel stem cell models help unpick the pathogenesis of the Triple A Syndrome?
Thu 08 13:48
OC5.4
Endocrine Main Meeting: Oral Communications 5
Fourteen years experience of hydrocortisone pump therapy for cortisol replacement in adrenal insufficiency
Thu 08 13:54
OC5.5
Endocrine Main Meeting: Oral Communications 5
New insights into the Low Dose Dexamethasone Suppression Test in paediatric Cushing’s Syndrome (CS)
Thu 08 14:00
OC5.6
Endocrine Main Meeting: Oral Communications 5
Successes and challenges around cohorted introduction of Burosumab in clinical treatment of X-Linked Hypophosphataemia (XLH)
Thu 08 14:06
OC5.7
Endocrine Main Meeting: Oral Communications 5
A novel GHR pseudoexon mutation causing frameshift and severe postnatal growth failure
London, UK
Thu 08 14:12
OC5.8
Endocrine Main Meeting: Oral Communications 5
Patients with short stature and GH/IGF-1 Insensitivity harbour Copy Number Variants causing a Silver-Russell-like Phenotype
London, UK
Thu 08 14:18
OC5.9
Endocrine Main Meeting: Oral Communications 5
Diazoxide-induced pulmonary hypertension: UK multicentre retrospective study on the risk factors, monitoring approach andmanagement recommendations
Glasgow, UK
Thu 08 15:30
SY2.1
Symposium 2
Vitamin D - Beyond Bone
Birmingham, UK
Thu 08 16:00
SY2.2
Symposium 2
State of the Art Lecture: 20 years experience in Metabolic Bone
Thu 08 16:30
S5
Key Note Speaker: Session 5
Palaeopathology; diseases and excavations
Wed 07 10:30
Tea & Coffee
Mezzanine
Wed 07 12:40
Lunch
Mezzanine
Wed 07 15:00
Tea & Coffee
Mezzanine
Thu 08 10:30
Tea & Coffee
Mezzanine
Thu 08 12:30
Lunch, exhibition & poster tours
Mezzanine
Thu 08 14:30
Tea, coffee & poster tours
Mezzanine
Fri 09 11:00
Tea & Coffee
Mezzanine
Fri 09 13:30
Lunch, exhibition and poster tours
Mezzanine
Thu 08 09:00
Endocrine Main Meeting - Nurses' AGM
Chairs: Stephanie Kerr (Southampton) & Kate Davies (London)
Thu 08 09:45
PENS1.1
PENS Presentation Session
Polycystic Kidney Disease with Hyperinsulinemic hypoglycaemia
Thu 08 10:05
PENS1.2
PENS Presentation Session
PENS BSPED Prize: The Implementation of a Nurse Led Virtual Thyroid Clinic
Fri 09 09:30
ND1.1
Nurses' Day for Endocrine Professionals: Session 1
Gender Identity
Fri 09 10:00
ND1.2
Nurses' Day for Endocrine Professionals: Session 1
Supporting Gender variant young people and their families
Fri 09 10:30
OC8.1
Nurses Day for Endocrine Professionals: Oral Communications 8
Five year outcomes in a cohort with hypoglycaemia due to Congenital Hyperinsulinism
Fri 09 10:40
OC8.2
Nurses Day for Endocrine Professionals: Oral Communications 8
The effect of GnRHa treatment on bone density in young adolescents with gender dysphoria: findings from a large national cohort
Fri 09 10:50
OC8.3
Nurses Day for Endocrine Professionals: Oral Communications 8
Attitudes Toward Fertility and Reproductive Health Among Transgender Adolescents
Fri 09 11:30
ND2.1
Nurses' Day for Endocrine Professionals: Session 2
Meet The Expert: Clincal differential diagnosis in short stature syndrome
Fri 09 12:30
ND2.2
Nurses' Day for Endocrine Professionals: Session 2
Patient experience: Growing Up with Russell Silver Syndrome
Fri 09 14:30
SY5.1
Symposium 5
Pituitary Tumours
Birmingham, UK
Fri 09 15:00
SY5.2
Symposium 5
Thyrotoxicosis – what’s new and where are we going?
Newcastle, UK
Fri 09 15:30
SY5.3
Symposium 5
State of the Art Lecture: NESGAS
Birmingham, UK
Wed 07 09:00
CME1.1
CME Day: Session 1
Techniques to maximise childhood and adult height
London, UK
Wed 07 09:30
CME1.2
CME Day: Session 1
Hypogonadotrophic hypogonadism - challenges in diagnosis and management
Wed 07 11:00
CME2.1
CME Day: Session 2
Management of Obesity- what works ?
Southampton, United Kingdom
Wed 07 11:30
CMW2.2
CME Day: Session 2
Management of growth and body composition in Prader Willi syndrome
Wed 07 13:30
CME3.1
CME Day: Session 3
Approach to a child with recurrent fractures
Wed 07 14:00
CME3.2
CME Day: Session 3
Assessment and management of Tall stature
Birmingham, UK
Wed 07 15:30
CME4.1
CME Day: Session 4
Structured pathway for management of High HbA1c
Wed 07 15:50
CME4.2
CME Day: Session 4
Role of youth worker, family support and social worker in supporting diabetes management
Wed 07 16:15
CME Officer's Update & Conclusion
The Studio
Wed 07 16:40
Sponsored Symposium
Wed 07 08:00
Registration
Thu 08 08:00
Registration
Thu 08 17:15
BSPED AGM
The Studio
Fri 09 08:00
Registration
Fri 09 13:15
BSPED 2018 Awards Session
The Studio
Fri 09 11:30
OC7.1
Diabetes Main Meeting: Oral Communications 7
DeAPP (Diabetes Education APP): using flipped learning to deliver structured education in newly diagnosed type 1 diabetes patients
Fri 09 11:40
OC7.2
Diabetes Main Meeting: Oral Communications 7
Provision of Psychology Services for Children and Young People with Diabetes: A National Survey
Fri 09 11:50
OC7.3
Diabetes Main Meeting: Oral Communications 7
The Determinants of Skeletal Morbidity And Fractures In Children With Type 1 Diabetes
Glasgow, UK
Fri 09 12:00
OC7.4
Diabetes Main Meeting: Oral Communications 7
Parental language proficiency and glycaemic control in children with type 1 diabetes
Fri 09 12:10
OC7.5
Diabetes Main Meeting: Oral Communications 7
Diabetes control is worse in children and young people with type 1 diabetes requiring interpreter support
Birmingham, UK
Fri 09 12:20
OC7.6
Diabetes Main Meeting: Oral Communications 7
Type A Insulin Resistance Syndrome due to anINSRmutation Presenting with Diabetes Mellitus Evolving to Hyperandrogenism and PCOS
Fri 09 12:30
OC7.7
Diabetes Main Meeting: Oral Communications 7
Knowledge and Confidence of Paediatric Middle Grade Doctors in Managing Out of Hours Diabetes Advice Calls
Sheffield, UK
Fri 09 12:40
OC7.8
Diabetes Main Meeting: Oral Communications 7
Continuous Glucose Monitoring with Regular Clinical Review of Glycaemic Control in Children with Type 1 Diabetes Experiencing Frequent Unpredictable Hypoglycaemia.

0 result(s) found.